S15 Diagnostic and Therapeutic Approaches To Growth Plate Disorders

Program: Symposia
Clinical/Translational Session
Thursday, March 5, 2015: 4:30 PM-6:00 PM
Room 11 (San Diego Convention Center)
**This session is eligible for CME credit**

Supported by Novo Nordisk Inc.

Chair:
Lars S Savendahl, MD, PhD, Karolinska Institutet, Stockholm, Sweden

Disclosures:
LSS: Consultant, Pfizer, Inc., Clinical Researcher, Merck & Co., Consultant, Novo Nordisk, Speaker, Ferring Pharmaceuticals, Clinical Researcher, Serono.

A complex array of genes regulate epiphyseal development and growth. These genes, products, and their interactions in the growth plate will be reviewed.

4:30 PM
Jeffrey Baron, MD, NICHD, NIH, Bethesda, MD
Nothing to Disclose: JB
5:00 PM
Robert C. Olney, MD, Dept. of Pediatrics/Endocrinology, Nemours Children's Clinic, Jacksonville, FL
Nothing to Disclose: RCO
5:30 PM
Gerhard Binder, MD, Pediatric Endocrinology, University Children's Hospital, Tuebingen, Germany
Disclosure: GB: Speaker, Ipsen, Speaker, Ferring Pharmaceuticals, Speaker, Eli Lilly & Company, Speaker, Merck & Co., Speaker, Novo Nordisk, Speaker, Sandoz, Speaker, Pfizer, Inc., Principal Investigator, Pfizer, Inc..
See more of: Symposia